New data from two clinical studies demonstrated that Sarclisa administered subcutaneously via an investigational on-body injector shortened treatment time to minutes with similar efficacy and safety ...

MetaRouter, a provider of server-side tag management, revealed enhancements to its Sync Injector feature, which is designed to enable anonymous and known user tracking via server-side event routing ...

MetaRouter's game-changing Sync Injector empowers companies to move their third-party tags server-side without compromise by using novel pathways to negotiate for and surface anonymous tracking IDs.

A month away from the PDUFA decision date for a Leqembi (lecanemab) subcutaneous autoinjector to be used for maintenance dosing for those with early Alzheimer’s disease, Eisai Co. Ltd. and Biogen Inc.